NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, […]
NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, […]
NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of NuScale Power Corporation (“NuScale” or the “Company”) (NYSE: SMR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, […]
NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Sprinklr, Inc. (“Sprinklr” or the “Company”) (NYSE: CXM). Such investors are advised to contact Danielle Peyton at [email protected] or […]
NEW YORK, Aug. 26, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against CAE Inc. (“CAE” or the “Company”) (NYSE: CAE). Such investors are advised to contact Danielle Peyton at [email protected] […]
